Amyotrophic Lateral Sclerosis and a "Death With Dignity".
Jennifer A AndersenPublished in: Omega (2018)
The Oregon "Death With Dignity" Act (DWD Act) allows a terminally ill patient with 6 months to live to ask a physician for medication to end their life. To receive the medication, the DWD Act requires the patient to verbally request the prescription twice 2 weeks apart as well as in writing. Patients with amyotrophic lateral sclerosis have three main barriers to using DWD: (a) the ability to communicate their informed consent as the disease progresses further, (b) the possibility of dementia which may affect their decisional capacity, and (c) given the nature and speed of amyotrophic lateral sclerosis, limited time is available for patients to self-administer the prescription and may rush the time line for the death. This article reviews the current knowledge and addresses the need for adjustments to existing law and recommendations for states considering a DWD law.
Keyphrases
- amyotrophic lateral sclerosis
- end stage renal disease
- healthcare
- case report
- newly diagnosed
- ejection fraction
- chronic kidney disease
- emergency department
- primary care
- mild cognitive impairment
- prognostic factors
- adverse drug
- advanced cancer
- peritoneal dialysis
- randomized controlled trial
- palliative care
- patient reported outcomes
- clinical practice
- patient reported
- meta analyses